Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?

Author(s): Antonis S. Manolis*, Athanasios G. Tzioufas

Journal Name: Current Vascular Pharmacology

Volume 18 , Issue 5 , 2020

Become EABM
Become Reviewer

Abstract:

In the current Thematic Issue of Current Vascular Pharmacology (CVP), entitled “Systemic Autoimmune Rheumatic Diseases and Cardiology”, presented in two parts, Part 1 and Part 2, review articles are included from specialists in cardiology, rheumatology, immunology and related fields. These reviews discuss the cardiovascular complications of the main systemic Autoimmune Rheumatic Diseases (ARDs). For example, the underlying pathogenetic mechanisms, the role of cardiovascular imaging and recommendations for prevention and management. These articles place inflammation as the key process, linking cardiovascular complications with ARDs. From all these reviews, the conclusion is the need for collaboration between the disciplines of Rheumatology and Cardiology to establish the emerging field of Cardio- Rheumatology. This will aid to fine-tune risk stratification and optimize preventive strategies and pharmacological therapies for patients with ARDs.

Keywords: Autoimmune rheumatic disease, cardiovascular disease, cardiorheumatology, rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s disease, spondyloarthropathies, systemic sclerosis, psoriasis, psoriatic arthritis, vasculitis, antirheumatic drugs, cardiovascular imaging, coronary artery disease, acute coronary syndromes, atherosclerosis, myocardial infarction, stroke.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 5
Year: 2020
Page: [425 - 430]
Pages: 6
DOI: 10.2174/1570161118666200514222236

Article Metrics

PDF: 9